According to a different study, mutations in BRCA1/2 were most commonly detected in ovarian (15.2%), prostate, (10.7%) breast (8.8%) and pancreatic cancer (5.2%) [12]. The gene discussed is BRCA1; the disease is familial pancreatic carcinoma.